Cargando…

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)

SIMPLE SUMMARY: Radioembolization is a kind of internal radiation therapy which is currently used in non-operable HCC. Several radiolabeled product can be used as (90)Y-loaded microspheres or less frequently radiolabeled lipiodol either with iodine 131 (in the past) or currently with rhenium 188 ((1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garin, Etienne, Palard, Xavier, Rolland, Yan, Le Sourd, Samuel, Lepareur, Nicolas, Ardisson, Valérie, Bouvry, Christelle, Laffont, Sophie, Campillo-Gimenez, Boris, Bellissant, Eric, Edeline, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137154/ https://www.ncbi.nlm.nih.gov/pubmed/37190173 http://dx.doi.org/10.3390/cancers15082245

Ejemplares similares

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside
por: Lepareur, Nicolas, et al.
Publicado: (2012)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
por: Palard, Xavier, et al.
Publicado: (2017)

Biodistribution, pharmacokinetics, and organ-level dosimetry for (188)Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans
por: Esquinas, Pedro L., et al.
Publicado: (2018)

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

(188) Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)—A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy
por: Kumar, Naresh, et al.
Publicado: (2023)

Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design
por: Garin, Etienne, et al.
Publicado: (2020)

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
por: Lenoir, Laurence, et al.
Publicado: (2012)

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with (188)Re
por: De La Vega, José Carlos, et al.
Publicado: (2019)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013)

External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015)

(68)Ga and (188)Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
por: Verger, Elise, et al.
Publicado: (2016)

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)

Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021)

Locoregional Confinement and Major Clinical Benefit of (188)Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma
por: Séhédic, Delphine, et al.
Publicado: (2017)

Initial Study of Radiological and Clinical Efficacy Radioembolization Using (188)Re-Human Serum Albumin (HSA) Microspheres in Patients with Progressive, Unresectable Primary or Secondary Liver Cancers
por: Nowicki, Mirosław L., et al.
Publicado: (2014)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

Preparation and biodistribution of (188)Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles ((188)Re-folate-CDDP/HSA MNPs) in vivo
por: Tang, Qiu-Sha, et al.
Publicado: (2011)

The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
por: Sun, HongLiang, et al.
Publicado: (2017)

SSS transport
por: Sylvie Prodon
Publicado: (2006)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
por: Pracht, M., et al.
Publicado: (2013)

Study of Binding Kinetics and Specificity of (99m)Tc-SSS-Complex and (99m)Tc-HMPAO to Blood Cells
por: Auletta, S., et al.
Publicado: (2018)

Preparation, Characterization, and Preliminary Imaging Study of [(188)Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis
por: Xu, Tingting, et al.
Publicado: (2022)

Preparation for and installation of SSS'S
por: Rohmig, P
Publicado: (2003)

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients
por: Braat, Manon N. G. J. A., et al.
Publicado: (2017)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Intratumoral Injection of (188)Re labeled Cationic Polyethylenimine Conjugates: A Preliminary Report
por: Kim, Eun-Mi, et al.
Publicado: (2004)

Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma
por: Shih, Ying-Hsia, et al.
Publicado: (2014)

Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer
por: Xiao, Jie, et al.
Publicado: (2016)

Efficacy and Safety of Combined Ethanol-Lipiodol Mixture and Drug-Eluting Bead TACE for Large HCC
por: Chuang, Yi-Hsuan, et al.
Publicado: (2023)

Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies – Experience in tertiary care oncology center in India
por: Bhargavi, Vidya, et al.
Publicado: (2019)

The neutron capture cross sections of 186;187;188 Os and their application to Re/Os cosmochronometer
por: Fujii, Kaori
Publicado: (2009)

Transarterial Radioembolization (TARE) with (131) Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
por: Patel, Aakash, et al.
Publicado: (2021)

Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
por: Dioguardi Burgio, Marco, et al.
Publicado: (2019)

Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
por: Vanpouille-Box, Claire, et al.
Publicado: (2011)

Lipiodol and the Lung
Publicado: (1935)

Re-Visiting the Embryogenesis of the Human Lower Lip: An Overlooked Paradigm
por: Vastardis, Heleni, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_aot5sri39rmeb0rhe27hhsbim8